WHO WE ARE

We are a group of dedicated scientific, medical, and business professionals who are driven to find treatments and cures to a variety of diseases. By attacking the disease directly with our novel TIMP/IMP technology and working strategically with our medical and scientific partners we seek to provide treatments and cures previously unavailable to doctors and their patients.

OUR TEAM

John. J. Puisis

Co-Founder, President and Chief Executive Officer

Catherine “Kitty” Mackey, PHD

Chairman of the Board

Jim Herrmann

Co-founder, Chief Operating Officer

Mary Beth Holum

Director of Clinical Operations

Adam Elhofy, PHD

Vice President of Product Research and Collaborations

Daniel R. Getts, PHD

Co-Founder,
Immunology

Michael Boyne, PHD

Analytics and Quality

Frank Fokta, PHD

Director of Quality

Jill Heady

Vice President of Finance and Administration

Olga Jasinsky

Director of Operations

Joseph Podojil, PHD

Senior Scientist

Ryan Pearson, PHD

Scientist I – Polymer

Sam Magnuson

Business Analyst

Linda Boerema

Office Administration

MEDICAL & SCIENCE PARTNERS

Roy First, MD

Medical Advisor

Kari Nadeau, MD, PHD

Stanford University

Ciaran P. Kelly, MD

Harvard Medical School

Stephen D. Miller, PHD

Northwestern University

Nick King, MD, PHD

University of Sydney Australia

Lonnie D. Shea, PHD

University of Michigan